Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 15, 2017
Impaired innate immune cells in cystic fibrosis: Is it really a surprise?
Tracey Bonfield, James F Chmiel
Respiratory Research
|
September 27, 2003
State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
James F Chmiel, Pamela B Davis
Clinics in Chest Medicine
|
May 1, 2007
Inflammation and anti-inflammatory therapies for cystic fibrosis
James F Chmiel, Michael W Konstan
Treatments in Respiratory Medicine
|
August 10, 2005
Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent
James F Chmiel, Michael W Konstan
Pediatric Pulmonology
|
September 4, 2015
Inflammation and its genesis in cystic fibrosis
David P Nichols, James F Chmiel
Pediatric Pulmonology
|
September 17, 2020
Drug development for cystic fibrosis
Don B Sanders, James F Chmiel
The Journal of Pediatrics
|
August 28, 2012
The impact of the Clean Air Act
Kristie Ross, James F Chmiel, Thomas Ferkol
Methods in Molecular Medicine
|
March 29, 2002
Murine models of CF airway infection and inflammation
James F Chmiel, Michael W Konstan, Melvin Berger
Clinical Reviews in Allergy & Immunology
|
August 7, 2002
The role of inflammation in the pathophysiology of CF lung disease
James F Chmiel, Melvin Berger, Michael W Konstan
Clinical Reviews in Allergy & Immunology
|
June 12, 2008
Anti-inflammatory therapies for cystic fibrosis-related lung disease
David P Nichols, Michael W Konstan, James F Chmiel
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 15, 2017
Impaired innate immune cells in cystic fibrosis: Is it really a surprise?
Tracey Bonfield, James F Chmiel
Respiratory Research
|
September 27, 2003
State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
James F Chmiel, Pamela B Davis
Clinics in Chest Medicine
|
May 1, 2007
Inflammation and anti-inflammatory therapies for cystic fibrosis
James F Chmiel, Michael W Konstan
Treatments in Respiratory Medicine
|
August 10, 2005
Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent
James F Chmiel, Michael W Konstan
Pediatric Pulmonology
|
September 4, 2015
Inflammation and its genesis in cystic fibrosis
David P Nichols, James F Chmiel
Pediatric Pulmonology
|
September 17, 2020
Drug development for cystic fibrosis
Don B Sanders, James F Chmiel
The Journal of Pediatrics
|
August 28, 2012
The impact of the Clean Air Act
Kristie Ross, James F Chmiel, Thomas Ferkol
Methods in Molecular Medicine
|
March 29, 2002
Murine models of CF airway infection and inflammation
James F Chmiel, Michael W Konstan, Melvin Berger
Clinical Reviews in Allergy & Immunology
|
August 7, 2002
The role of inflammation in the pathophysiology of CF lung disease
James F Chmiel, Melvin Berger, Michael W Konstan
Clinical Reviews in Allergy & Immunology
|
June 12, 2008
Anti-inflammatory therapies for cystic fibrosis-related lung disease
David P Nichols, Michael W Konstan, James F Chmiel
Page
of 7